MedPath

Riboflavin 5'-Phosphate Sodium

Generic Name
Riboflavin 5'-Phosphate Sodium

Overview

No overview information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Sandoz Inc
54643-9023
INTRAVENOUS
1.4 mg in 5 mL
10/28/2016
Sandoz Inc
54643-9015
INTRAVENOUS
3.6 mg in 10 mL
10/28/2016
Raw Materials International Overseas LLC
69877-026
INTRAMUSCULAR, INTRAVENOUS
2 mg in 1 mL
12/31/2015
Glaukos Corporation
25357-022
OPHTHALMIC
1.56 mg in 1 mL
11/16/2023
Merit Pharmaceutical
30727-300
INTRAMUSCULAR, INTRAVENOUS
2 mg in 1 mL
12/4/2020
Sandoz Inc
54643-7874
INTRAVENOUS
3.6 mg in 10 mL
10/28/2016
Sandoz Inc
54643-5650
INTRAVENOUS
3.6 mg in 10 mL
3/17/2016
FLON LABORATORIES LLC
71414-225
INTRAVENOUS, INTRAMUSCULAR
2 mg in 1 mL
9/29/2017
Sparhawk Laboratories, Inc.
58005-606
INTRAMUSCULAR, SUBCUTANEOUS, INTRAVENOUS
5 mg in 1 mL
4/9/2025
Sandoz Inc
54643-5649
INTRAVENOUS
3.6 mg in 10 mL
3/17/2016

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
B COMPLEX W C AND B12 INJ
e l stickley and co ltd.
00549762
Liquid - Intravenous ,  Intramuscular
50 MG / 10 ML
12/31/1963
MVC 9 PLUS 3 INJ
lyphomed, division of fujisawa canada inc.
01945637
Liquid - Intravenous
3.6 MG / 5 ML
12/31/1984
VITAMIN AND MINERAL SUPPLEMENT - LIQ
technilab pharma inc.
02213869
Liquid - Oral
1 MG / 10 ML
5/25/1998
MVC 9+4 INJ
lyphomed canada inc.
00871990
Liquid - Intravenous
1.4 MG / 10 ML
12/31/1990
VITAMINE 110 LIQ
frega inc.
02008068
Liquid - Oral
2.5 MG / 5 ML
12/31/1993
TONICOL ET A-D-C AMPOULES/COMPRIMES
distributions multi-pro inc.
00730769
Tablet ,  Liquid - Oral
2 MG / PCK
12/31/1988
PARAMETTES SYRUP
wyeth-ayerst canada inc.
02043084
Syrup - Oral
.2 MG / ML
12/31/1994
DYNAM AMPOULE ET TABLET
cardinaux enrg les produits naturels
00724491
Tablet ,  Liquid - Oral
2 MG / 10 ML
12/31/1989

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.